Droxidopa
Droxidopa is a pharmaceutical drug with 28 clinical trials. Currently 1 active trials ongoing. Historical success rate of 75.0%.
Success Metrics
Based on 15 completed trials
Phase Distribution
Phase Distribution
9
Early Stage
7
Mid Stage
9
Late Stage
Highest Phase Reached
Phase 4Trial Status & Enrollment
65.2%
15 of 23 finished
34.8%
8 ended early
1
trials recruiting
28
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
NORTHERA (DROXIDOPA) for Dysautonomia in Adult Survivors of Menkes Disease and Occipital Horn Syndrome
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
Droxidopa / Pyridostigmine in Orthostatic Hypotension
Study To Assess The Clinical Benefit Of Droxidopa And Droxidopa/Carbidopa In Subjects With Fibromyalgia
Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) (Droxi-304)
Clinical Trials (28)
NORTHERA (DROXIDOPA) for Dysautonomia in Adult Survivors of Menkes Disease and Occipital Horn Syndrome
Effects of Midodrine and Droxidopa on Splanchnic Capacitance in Autonomic Failure
Droxidopa / Pyridostigmine in Orthostatic Hypotension
Study To Assess The Clinical Benefit Of Droxidopa And Droxidopa/Carbidopa In Subjects With Fibromyalgia
Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH) (Droxi-304)
Brain Perfusion & Oxygenation in Parkinson's Disease With NOH
Safety and Efficacy of Droxidopa for Fatigue in Patients With Parkinsonism
Norepinephrine-targeted Therapy for Action Control in Parkinson Disease
Effect of L-Dihydroxyphenylserine (L-DOPS) on Falls in Patients With Neurogenic Orthostatic Hypotension (NOH)
Effects of Droxidopa When Measuring Gait Speed, Kyphosis, and Functional Reach in Parkinson's Disease
Hemodynamic Response of Neuropathic And Non-Neuropathic POTS Patients To Adrenoreceptor Agonist And Antagonist
Study to Assess the Clinical Benefit and Safety of Droxidopa in Parkinson's Disease
Long Term Treatment With L-DOPS
A Clinical Study of Patients With Symptomatic NOH to Assess Sustained Effects of Droxidopa Therapy
Augmenting Effects of L-DOPS With Carbidopa and Entacapone
Safety and Benefit Study of Droxidopa to Treat Patients With Intradialytic Hypotension
Study To Assess The Clinical Benefit Of Droxidopa In Subjects With Chronic Fatigue Syndrome
Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)
A Two Part Study (306A/306B) to Assess Droxidopa in Treatment of NOH in Patients With Parkinson's Disease
Open-Label Clinical Study of Droxidopa in Patients With Neurogenic Orthostatic Hypotension (NOH)
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 28